← SynDRA
WX-UK1
SynDRA canonical compound SYN1955583 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PLAU |
|---|
| Mechanism of action | urokinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- urokinase inhibitor
- PLAU INHIBITOR
Cross-references
Synonyms
- UKI-1
- UNII-00LOF6890B
- CHEMBL107955
- 00LOF6890B
- Wx-uk1 free base
- compound 2r-L
- GTPL6498
- BDBM23891
- 3-amidinophenylalanine deriv., 35
- ZINC4426028
- AKOS030526723
- CS-5726
- HY-100415
- 1-Piperazinecarboxylic acid, 4-((2S)-3-(3-(aminoiminomethyl)phenyl)-1-oxo-2-(((2,4,6-tris(1-methylethyl)phenyl)sulfonyl)amino)propyl)-, ethyl ester
- ethyl 4-[(2S)-3-(3-carbamimidoylphenyl)-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperazine-1-carboxylate
- ethyl 4-[(2S)-3-(3-carbamimidoylphenyl)-2-{[2,4,6
Look up WX-UK1 in the interactive SynDRA portal →